Vitamin D supplementation and lipid profile: What does the best available evidence show?

Atherosclerosis

Volumn 235, Issue 1, 2014, Pages 130-139

  Challoumas, Dimitrios ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

25 OH D; Effects; HDL; LDL; Lipids; Randomized controlled trials; Supplements; Triglycerides; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; CHOLESTEROL; COLECALCIFEROL; ERGOCALCIFEROL; ESTROGEN RECEPTOR; FIBRINOLYTIC FACTOR; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PLACEBO; PLATELET ACTIVATION INHIBITOR 1; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VITAMIN D; 25-HYDROXYVITAMIN D; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHINA; CHOLESTEROL BLOOD LEVEL; HEART INFARCTION; HORMONAL THERAPY; HUMAN; LIPID BLOOD LEVEL; META ANALYSIS (TOPIC); OBESITY; PARATHYROID HORMONE BLOOD LEVEL; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENT; MOUSE; OBSERVATIONAL STUDY;

ANIMALS; CALCIUM; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENTS; HUMANS; LIPIDS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; MICE; OBSERVATIONAL STUDIES AS TOPIC; PARATHYROID HORMONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D;

EID: 84901838778     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.04.024     Document Type: Review

References (67)

1. Challoumas D., Cobbold C., Dimitrakakis G. Effects of calcium intake on the cardiovascular system in postmenopausal women. Atherosclerosis 2013, 231(1):1-7.
2. Ku Y.C., Liu M.E., Ku C.S., Liu T.Y., Lin S.L. Relationship between vitamin D deficiency and cardiovascular disease. World J Cardiol 2013, 5(9):337-346.
3. Norman A.W., Bouillon R., Whiting S.J., Vieth R., Lips P. 13th Workshop consensus for vitamin D nutritional guidelines. JSteroid Biochem Mol Biol 2007, 103:204-205.
4. Poole K.E., Loveridge N., Barker P.J., Halsall D.J., Rose C., Reeve J., et al. Reduced vitamin D in acute stroke. Stroke 2006, 37:243-245.
5. Scragg R., Jackson R., Holdaway I.M., Lim T., Beaglehole R. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study. Int J Epidemiol 1990, 19:559-563.
6. Meredith A.J., Mcmanus B.M. Vitamin D in heart failure. JCard Fail 2013, 19(10):692-711.
7. Ebert R., Schutze N., Adamski J., Jakob F. Vitamin D signaling is modulated on multiple levels in health and disease. Mol Cell Endocrinol 2006, 248:149-159.
8. Messa P., Curreri M., Regalia A., Alfieri C.M. Vitamin D and the cardiovascular system: an overview of the recent literature. Am J Cardiovasc Drugs 2013, [Epub ahead of print].
9. Tripkovic L., Lambert H., Hart K., Smith C.P., Bucca G., Penson S., et al. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin Nutr 2012, 95(6):1357-1364.
10. Bjelakovic G., Gluud L.L., Nikolova D., Whitfield K., Wetterslev J., Simonetti R.G., et al. Vitamin D supplementation for prevention of mortality in adults. Cochrane Database Syst Rev 2011, 6(7). CD007470.
11. Messenger W., Nielson C.M., Li H., Beer T., Barrett-Connor E., Stone K., et al. Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis 2012, 22:856-863.
12. Wang T.J., Pencina M.J., Booth S.L., Jacques P.F., Ingelsson E., Lanier K., et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008, 117:503-511.
13. Kestenbaum B., Katz R., de Boer I., Hoofnagle A., Sarnak M.J., Shlipak M.G., et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol 2011, 58(14):1433-1441.
14. Kojima G., Bell C., Abbott R.D., Launer L., Chen R., Motonaga H., et al. Low dietary vitamin D predicts 34-year incident stroke: the Honolulu heart program. Stroke 2012, 43(8):2163-2167.
15. Hutchinson M.S., Grimnes G., Joakimsen R.N., Figenschau Y., Jorde R. Low serum 25-hydroxyvitamin D levels are associated with increased all-cause mortality risk in a general population: the Tromso study. Eur J Endocrinol 2010, 162:935-942.
16. Autier P., Gandini S. Vitamin D supplementation and total mortality. Arch Intern Med 2007, 167(16):1730-1737.
17. Chaudhuri J.R., Mridula K.R., Anamika A., Boddu D.B., Misra P.K., Lingaiah A., et al. Deficiency of 25-hydroxyvitamin d and dyslipidemia in Indian subjects. J Lipids 2013, 2013:623420.
18. Karhapää P., Pihlajamäki J., Pörsti I., Kastarinen M., Mustonen J., Niemela O., et al. Diverse associations of 25-hydroxyvitamin D and 1,25-dihydroxy-vitamin D with dyslipidaemias. J Intern Med 2010, 268(6):604-610.
19. Jorde R., Figenschau Y., Hutchinson M., Emaus N., Grimnes G. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur J Clin Nutr 2010, 64(12):1457-1464.
20. Ponda M.P., Huang X., Odeh M.A., Breslow J.L., Kaufman H.W. Vitamin D may not improve lipid levels: a serial clinical laboratory data study. Circulation 2012, 126(3):270-277.
21. Kelishadi R., Farajzadegan Z., Bahreynian M. Association between vitamin D status and lipid profile in children and adolescents: a systematic review and meta-analysis. Int J Food Sci Nutr 2014, [Epub ahead of print].
22. Gonzalez F.J., Moschetta A. Potential role of the vitamin D receptor in control of cholesterol levels. Gastroenterology 2014 Feb 21, pii:S0016-5085(14) 00233.
23. Jiang W., Miyamoto T., Kakizawa T., Nishio S.I., Oiwa A., Takeda T., et al. Inhibition of LXRalpha signaling by vitamin D receptor: possible role of VDR in bile acid synthesis. Biochem Biophys Res Commun 2006, 351:176-184.
24. Honjo Y., Sasaki S., Kobayashi Y., Misawa H., Nakamura H. 1,25-Dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor. J Endocrinol 2006, 188:635-643.
25. Chow E.C., Magomedova L., Quach H.P., Patel R., Durk M.R., Fan J., et al. Vitamin D receptor activation down-regulates the small heterodimer partner and increases CYP7A1 to lower cholesterol. Gastroenterology 2014, 146(4):1048-1059.
26. Schmidt D.R., Holmstrom S.R., Fon Tacer K., Bookout A.L., Kliewer S.A., Mangelsdorf D.J., et al. Regulation of bile acid synthesis by fat-soluble vitamins A and D. JBiol Chem 2010, 285:14486-14494.
27. Wang J.H., Keisala T., Solakivi T., et al. Serum cholesterol and expression of ApoAI, LXRbeta and SREBP2 in vitamin D receptor knock-outmice. JSteroid Biochem Mol Biol 2009, 113(3-5):222-226.
28. Schmidt N., Brandsch C., Schutkowski A., Hirche F., Stangl G.I. Dietary vitamin D inadequacy accelerates calcification and osteoblast-like cell formation in the vascular system of LDL receptor knockout and wild-type mice. JNutr 2014, [Epub ahead of print].
29. Bouillon R., Carmeliet G., Verlinden L., et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 2008, 29(6):726-776.
30. Szeto F.L., Reardon C.A., Yoon D., et al. Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol Endocrinol 2012, 26(7):1091-1101.
31. Li Y.C., Kong J., Wei M., et al. 1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system. JClin Invest 2002, 110(2):229-238.
32. Wu J., Garami M., Cheng T., et al. 1,25 (OH)2 Vitamin D3 and retinoic acid antagonize endothelin stimulated hypertrophy of neonatal rat cardiac myocytes. JClin Invest 1996, 97(7):1577-1588.
33. Mizobuchi M., Nakamura H., Tokumoto M., et al. Myocardial effects of VDR activators in renal failure. JSteroid Biochem Mol Biol 2010, 121(1-2):188-192.
34. Meems L.M., Cannon M.V., Mahmud H., et al. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload. JSteroid Biochem Mol Biol 2012, 132(3-5):282-289.
35. Kane L., Moore K., Lütjohann D., Bikle D., Schwartz J.B. Vitamin D3 effects on lipids differ in statin and non-statin-treated humans: superiority of free 25-OH D levels in detecting relationships. JClin Endocrinol Metab 2013, 98(11):4400-4409.
36. Ponda M.P., Dowd K., Finkielstein D., Holt P.R., Breslow J.L. The short-term effects of vitamin D repletion on cholesterol: a randomized, placebo-controlled trial. Arterioscler Thromb Vasc Biol 2012, 32(10):2510-2515.
37. Witham M.D., Adams F., Kabir G., Kennedy G., Belch J.J., Khan F. Effect of short-term vitamin D supplementation on markers of vascular health in South Asian women living in the UK - a randomised controlled trial. Atherosclerosis 2013, 230(2):293-299.
38. Witham M.D., Dove F.J., Khan F., et al. Effects of vitamin D supplementation on markers of vascular function after myocardial infarction - a randomised controlled trial. Int J Cardiol 2013, 167(3):745-749.
39. Zhou J.C., Zhu Y.M., Guo P., et al. Serum 25(OH)D and lipid levels in Chinese obese and normal weight males before and after oral vitamin D supplementation. Biomed Environ Sci 2013, 26(10):801-807.
40. Nagpal J., Pande J.N., Bhartia A. Adouble-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009, 26:19-27.
41. Jorde R., Sneve M., Torjesen P., Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D for 1 year. JIntern Med 2010, 267:462-472.
42. Scragg R., Khaw K.T., Murphy S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr 1995, 49:640-646.
43. Witham M.D., Dove F.J., Dryburgh M., et al. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010, 53:2112-2119.
44. Witham M.D., Dove F.J., Sugden J.A., Doney A.S., Struthers A.D. The effect of vitamin D replacement on markers of vascular health in stroke patients - a randomised controlled trial. Nutr Metab Cardiovasc Dis 2010, 22(10):864-870.
45. Chai W., Cooney R.V., Franke A.A., Bostick R.M. Effects of calcium and vitamin D supplementation on blood pressure and serum lipids and carotenoids: a randomized, double-blind, placebo-controlled, clinical trial. Ann Epidemiol 2013, 23(9):564-570.
46. Sai A.J., Gallagher J.C., Fang X. Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-α genotypes. Menopause 2011, 18(10):1101-1112.
47. Ljunghall S., Lind L., Lithell H., et al. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance- a prospective randomized double-blind study. Acta Med Scand 1987, 222(4):361-367.
48. Heikkinen A.M., Tuppurainen M.T., Niskanen L., et al. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol 1997, 137:495-502.
49. Andersen R., Brot C., Mejborn H., et al. Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants. Eur J Clin Nutr 2009, 63:1150-1153.
50. von Hurst P.R., Stonehouse W., Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient - a randomised, placebo-controlled trial. Br J Nutr 2010, 103:549-555.
51. Zittermann A., Frisch S., Berthold H.K., et al. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009, 89:1321-1327.
52. Yiu Y.F., Yiu K.H., Siu C.W., et al. Randomized controlled trial of vitamin D supplement on endothelial function in patients with type 2 diabetes. Atherosclerosis 2013, 227(1):140-146.
53. Maki K.C., Rubin M.R., Wong L.G., et al. Effects of vitamin D supplementation on 25-hydroxyvitamin D, high-density lipoprotein cholesterol, and other cardiovascular disease risk markers in subjects with elevated waist circumference. Int J Food Sci Nutr 2011, 62(4):318-327.
54. Jorde R., Grimnes G. Vitamin D and metabolic health with special reference to the effect of vitamin D on serum lipids. Prog Lipid Res 2011, 50:303-312.
55. Wang H., Xia N., Yang Y., Peng D.Q. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis 2012, 11:42.
56. Pfeifer M., Begerow B., Minne H.W., Nachtigall D., Hansen C. Effects of a shortterm vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. JClin Endocrinol Metab 2001, 86:1633-1637.
57. Huffman K.M., Hawk V.H., Henes S.T., et al. Exercise effects on lipids in persons with varying dietary patterns-does diet matter if they exercise? Responses in studies of a targeted risk reduction intervention through defined exercise I. Am Heart J 2012, 164(1):117-124.
58. Wacker M., Holick M.F. Vitamin D-effects on skeletal and extraskeletal health and the need for supplementation. Nutrients 2013, 5:111-148.
59. Jorde R., Grimnes G. Vitamin D and lipids: do we really need more studies?. Circulation 2012, 126:252-254.
60. Lewis J.R., Calver J., Zhu K., Flicker L., Prince R.L. Calcium supplementation and the risks of atherosclerotic vascular disease in older women: results of a 5-year RCT and a 4.5-year follow-up. JBone Miner Res 2011, 26(1):35-41.
61. Bolland M.J., Barber P.A., Doughty R.N. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008, 336:262-266.
62. Xiao Q., Murphy R.A., Houston D.K., et al. Dietary and supplemental calcium intake and cardiovascular disease mortality: the National Institutes of Health-AARP diet and health study. JAMA Intern Med 2013, 173(8):639-646.
63. Reid I.R., Mason B., Horne A., et al. Effects of calcium supplementation on serum lipid concentrations in normal older women: a randomized controlled trial. Am J Med 2002, 112(5):343-347.
64. Choi H.S., Kim S.H., Rhee Y., Cho M.A., Lee E.J., Lim S.K. Serum parathyroid hormone is associated with carotid intima-media thickness in postmenopausal women. Int J Clin Pract 2008, 62(9):1352-1357.
65. Snijder M.B., Lips P., Seidell J.C., et al. Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. JIntern Med 2007, 261(6):558-565.
66. He J.L., Scragg R.K. Vitamin D, parathyroid hormone, and blood pressure in the National Health and Nutrition Examination Surveys. Am J Hypertens 2011, 24(8):911-917.
67. Schnatz P.F., Jiang X., Vila-Wright S., et al. Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial. Menopause 2014, [Epub ahead of print].